• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Incomplete Estrogen Suppression With Gonadotropin-Releasing Hormone Agonists May Reduce Clinical Efficacy in Premenopausal Women With Early Breast Cancer.

作者信息

Dowsett Mitch, Lønning Per E, Davidson Nancy E

机构信息

Royal Marsden Hospital, London, United Kingdom

University of Bergen and Haukeland University Hospital, Bergen, Norway.

出版信息

J Clin Oncol. 2016 May 10;34(14):1580-3. doi: 10.1200/JCO.2015.62.3728. Epub 2016 Jan 4.

DOI:10.1200/JCO.2015.62.3728
PMID:26729430
Abstract
摘要

相似文献

1
Incomplete Estrogen Suppression With Gonadotropin-Releasing Hormone Agonists May Reduce Clinical Efficacy in Premenopausal Women With Early Breast Cancer.促性腺激素释放激素激动剂不完全抑制雌激素可能会降低绝经前早期乳腺癌女性的临床疗效。
J Clin Oncol. 2016 May 10;34(14):1580-3. doi: 10.1200/JCO.2015.62.3728. Epub 2016 Jan 4.
2
Luteinizing hormone-releasing hormone agonists in premenopausal hormone receptor-positive breast cancer.绝经前激素受体阳性乳腺癌中的促黄体生成素释放激素激动剂
Clin Breast Cancer. 2007 Feb;7(6):455-64. doi: 10.3816/CBC.2007.n.002.
3
Bilateral Salpingo-oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor-Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors.接受芳香化酶抑制剂治疗的激素受体阳性转移性乳腺癌绝经前患者中，双侧输卵管卵巢切除术与促性腺激素释放激素激动剂的比较。
Cancer Res Treat. 2017 Oct;49(4):1153-1163. doi: 10.4143/crt.2016.463. Epub 2017 Feb 27.
4
Adjuvant endocrine therapy in premenopausal women with breast cancer.绝经前乳腺癌女性的辅助内分泌治疗
Breast Cancer Res Treat. 2010 Sep;123 Suppl 1:43-7. doi: 10.1007/s10549-010-1045-2. Epub 2010 Aug 14.
5
3-month triptorelin in premenopausal patients with hormone receptor-positive early breast cancer: a commentary and a retrospective experience.3个月的曲普瑞林用于激素受体阳性早期乳腺癌绝经前患者：一篇评论及回顾性经验
Future Oncol. 2015;11(23):3109-12. doi: 10.2217/fon.15.261. Epub 2015 Nov 6.
6
Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials.促黄体生成素释放激素激动剂在激素受体阳性绝经前乳腺癌患者中作为辅助治疗的应用：来自随机辅助试验的个体患者数据的荟萃分析
Lancet. 2007 May 19;369(9574):1711-23. doi: 10.1016/S0140-6736(07)60778-8.
7
The Role of Gonadotropin-Releasing-Hormone Analogues in the Treatment of Breast Cancer.促性腺激素释放激素类似物在乳腺癌治疗中的作用。
J Womens Health (Larchmt). 2018 Apr;27(4):466-475. doi: 10.1089/jwh.2017.6355. Epub 2017 Sep 19.
8
LHRH-agonist versus chemotherapy in premenopausal breast cancer?绝经前乳腺癌中促黄体生成素释放激素激动剂与化疗的比较？
Eur J Cancer. 2002 Nov;38 Suppl 6:S45-6. doi: 10.1016/s0959-8049(02)00282-4.
9
Adjuvant hormonal therapy in premenopausal women with operable breast cancer: not-so-peripheral perspectives.绝经前可手术乳腺癌患者的辅助激素治疗：非外周观点。
Oncology (Williston Park). 2010 Apr 15;24(4):322-7.
10
Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials.他莫昔芬与促黄体生成素释放激素（LHRH）激动剂联合用药与单独使用LHRH激动剂治疗绝经前晚期乳腺癌的疗效比较：四项随机试验的荟萃分析
J Clin Oncol. 2001 Jan 15;19(2):343-53. doi: 10.1200/JCO.2001.19.2.343.

引用本文的文献

1
Clinical significance of serum estradiol monitoring in women receiving adjuvant aromatase inhibitor for hormone receptor-positive early breast cancer.接受辅助芳香化酶抑制剂治疗激素受体阳性早期乳腺癌的女性监测血清雌二醇的临床意义。
Breast. 2024 Dec;78:103818. doi: 10.1016/j.breast.2024.103818. Epub 2024 Sep 29.
2
Selection of appropriate biomarkers to monitor effectiveness of ovarian function suppression in pre-menopausal patients with ER+ breast cancer.选择合适的生物标志物以监测绝经前雌激素受体阳性乳腺癌患者卵巢功能抑制的有效性。
NPJ Breast Cancer. 2024 Jan 19;10(1):8. doi: 10.1038/s41523-024-00614-w.
3
Goserelin Ovarian Ablation Failure in Premenopausal Women With Breast Cancer.
戈舍瑞林对绝经前乳腺癌女性的卵巢去势失败
Cureus. 2021 Nov 15;13(11):e19608. doi: 10.7759/cureus.19608. eCollection 2021 Nov.
4
An Ultrasensitive Routine LC-MS/MS Method for Estradiol and Estrone in the Clinically Relevant Sub-Picomolar Range.一种用于临床相关亚皮摩尔范围内雌二醇和雌酮的超灵敏常规液相色谱-串联质谱法。
J Endocr Soc. 2020 Apr 21;4(6):bvaa047. doi: 10.1210/jendso/bvaa047. eCollection 2020 Jun 1.
5
Molecular changes in premenopausal oestrogen receptor-positive primary breast cancer in Vietnamese women after oophorectomy.越南女性绝经前雌激素受体阳性原发性乳腺癌患者卵巢切除术后的分子变化
NPJ Breast Cancer. 2017 Nov 27;3:47. doi: 10.1038/s41523-017-0049-z. eCollection 2017.
6
Current advances in endocrine therapy options for premenopausal women with hormone receptor positive breast cancer.激素受体阳性绝经前乳腺癌女性内分泌治疗选择的当前进展
Gynecol Oncol. 2017 Oct;147(1):153-157. doi: 10.1016/j.ygyno.2017.06.023. Epub 2017 Jun 26.
7
Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results.帕博西尼联合氟维司群治疗绝经前激素受体阳性晚期乳腺癌患者的效果：PALOMA-3 研究结果
Oncologist. 2017 Sep;22(9):1028-1038. doi: 10.1634/theoncologist.2017-0072. Epub 2017 Jun 26.
8
Ovarian Function Suppression in Premenopausal Women with Early-Stage Breast Cancer.绝经前早期乳腺癌女性的卵巢功能抑制
Curr Treat Options Oncol. 2017 Jan;18(1):4. doi: 10.1007/s11864-017-0442-8.